Buyback of Class B shares in Essity during week 6, 2026

Essity repurchased 69,537 Class B shares between Feb 2–6, 2026 as part of its SEK 3bn buyback program, paying a weekly weighted average price of SEK 269.79 for a total of SEK 18.76m. The program, announced April 23, 2025, has accumulated 10,326,818 repurchased shares valued at SEK 2,667,361,334 (weighted avg SEK 258.29); purchases were executed on Nasdaq Stockholm by BofA Securities. Post-week holdings were 11,109,318 Class B treasury shares and the company has 693,054,489 total shares outstanding; repurchases are financed from operating cash flow after the ordinary dividend and form part of Essity’s ongoing capital allocation policy.

Analysis

Market structure: The buyback removes ~10.33m B‑shares (≈1.49% of 693.05m shares) and leaves Essity with 11.11m treasury shares (~1.60% of issued), tightening free float and creating modest upward pressure on price and EPS over the next 3–6 months. Direct winners are existing equity holders (EPS accretion, lower share count) and liquidity providers executing block trades; short sellers and intraday liquidity seekers are losers as average daily availability shrinks ~1–2% on executed days. Cross-asset effects are muted but non‑zero: small downward pressure on short-term implied volatility for options, minor credit spread tightening if market views buyback as signal of strong cash flow, and negligible FX/commodity impacts given Essity’s consumer staples profile.

Risk assessment: Tail risks include a macro shock reducing operating cash flow (FCF) that forces buyback halt or dividend cut, regulatory scrutiny on treasury share use, or misuse of treasury stock in dilutive M&A; probability low but impact high. Immediate (days) effect = transient price uptick (1–3%); short term (weeks/months) = momentum as program nears completion; long term (quarters) = depends on FCF conversion—if trailing FCF yield falls below 4% the buyback is unsustainable. Hidden dependencies: buyback funded after ordinary dividend consumes buffer capital and can crowd out capex or R&D, compressing organic growth.

Trade implications: Tactical long in Essity B (Nasdaq Stockholm: ESSITY B) sized 1–3% of portfolio, staggered in 20% tranches: buy under SEK 270, add under SEK 260, target SEK 300 within 3–6 months, stop loss SEK 245. Options: consider a limited‑risk bull call spread (Jan 2027 270/320) sized to desired exposure or sell short-dated puts if premium >3% of notional and delta ~0.25. Relative value: pair long ESSITY B vs short Unilever (LSE: ULVR) or European consumer staples ETF to capture buyback-driven alpha; size 0.5–1% net.

Contrarian angles: Markets may underprice that the program is ~89% spent (≈SEK 2.67bn of SEK 3bn), meaning little incremental buyback remains absent fresh authorization—so upside from continued buys is limited. Conversely, consensus may be too optimistic about recurring buybacks; if trailing 12‑month FCF yield slips under 4% or net debt/EBITDA rises >2x, downside risk is asymmetric. Historical parallels: Swedish industrials that front-loaded buybacks often saw mean reversion when macro softened. Unintended consequence: large treasury balance gives management M&A optionality that could be value‑dilutive.

Key Decisions for Investors

• Establish a 1–3% long position in Essity B (Nasdaq Stockholm: ESSITY B) in 5 tranches over 4 weeks: execute 20% at market if price <270 SEK, add 20% if <260 SEK; target exit 300 SEK within 3–6 months and set hard stop-loss at 245 SEK.
• Implement a limited-risk options trade: buy Jan 2027 270/320 call spread sized to replicate 1% equity exposure (max loss = premium). Rationale: captures upside from remaining buyback/recurring buyback ambition with capped downside.
• Construct a 0.5–1% pair trade: long ESSITY B vs short Unilever (LSE: ULVR) equal notional, horizon 3–9 months, to isolate buyback-driven EPS accretion vs peers lacking equivalent capital returns; unwind if ESSITY underperforms ULVR by >6% in 30 days.
• Reduce or avoid new incremental exposure if trailing 12‑month free cash flow yield falls below 4% or net debt/EBITDA increases by >0.5x from current levels; if remaining authorized buyback capacity ≤SEK 500m, trim position by 50%.